Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Gaspar

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The International Journal of Lower Extremity Wounds|July 5, 2022
Full Diabetic Foot Ulcer Healing and Pain Relief Based on Platelet-Rich-Plasma gel Formulation Treatment and the Involved PathwaysKrissia Caroline Leme, Guilherme Martins Neri, Gabriel Gaspar Biscaro, et al.
International Journal of Clinical Pharmacy|May 27, 2015
Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patientsPedro Rodríguez Quesada, Laura López Esteban, Jimena Ramón García, et al.
Hepatology (Baltimore, Md.)|March 7, 2024
Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV-coinfected patients with advanced fibrosis/cirrhosisJuan Berenguer, Teresa Aldámiz-Echevarría, Víctor Hontañón, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 25, 2021
HIV/HBV coinfection: temporal trends and patient characteristics, Spain, 2002 to 2018Leire Pérez-Latorre, Juan Berenguer, Rafael Micán, et al.
Hepatology (Baltimore, Md.)|January 22, 2017
Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus/hepatitis C virus coinfectionJuan Berenguer, Elena Rodríguez-Castellano, Ana Carrero, et al.
Journal of Hepatology|February 12, 2013
Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virusJuan Berenguer, Julio Alvarez-Pellicer, Ana Carrero, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2012
Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and Hepatitis C virusJuan Berenguer, Elena Rodríguez, Pilar Miralles, et al.
Hepatology (Baltimore, Md.)|January 30, 2018
All-oral direct-acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV-coinfected subjects in real-world practice: Madrid coinfection registry findingsJuan Berenguer, Ángela Gil-Martin, Inmaculada Jarrin, et al.
HIV Medicine|January 17, 2022
Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019Chiara Fanciulli, Juan Berenguer, Carmen Busca, et al.
Open Forum Infectious Diseases|January 23, 2018
Human Immunodeficiency Virus/Hepatits C Virus Coinfection in Spain: Elimination Is Feasible, but the Burden of Residual Cirrhosis Will Be SignificantJuan Berenguer, Inmaculada Jarrín, Leire Pérez-Latorre, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The International Journal of Lower Extremity Wounds|July 5, 2022
Full Diabetic Foot Ulcer Healing and Pain Relief Based on Platelet-Rich-Plasma gel Formulation Treatment and the Involved PathwaysKrissia Caroline Leme, Guilherme Martins Neri, Gabriel Gaspar Biscaro, et al.
International Journal of Clinical Pharmacy|May 27, 2015
Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patientsPedro Rodríguez Quesada, Laura López Esteban, Jimena Ramón García, et al.
Hepatology (Baltimore, Md.)|March 7, 2024
Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV-coinfected patients with advanced fibrosis/cirrhosisJuan Berenguer, Teresa Aldámiz-Echevarría, Víctor Hontañón, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 25, 2021
HIV/HBV coinfection: temporal trends and patient characteristics, Spain, 2002 to 2018Leire Pérez-Latorre, Juan Berenguer, Rafael Micán, et al.
Hepatology (Baltimore, Md.)|January 22, 2017
Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus/hepatitis C virus coinfectionJuan Berenguer, Elena Rodríguez-Castellano, Ana Carrero, et al.
Journal of Hepatology|February 12, 2013
Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virusJuan Berenguer, Julio Alvarez-Pellicer, Ana Carrero, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2012
Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and Hepatitis C virusJuan Berenguer, Elena Rodríguez, Pilar Miralles, et al.
Hepatology (Baltimore, Md.)|January 30, 2018
All-oral direct-acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV-coinfected subjects in real-world practice: Madrid coinfection registry findingsJuan Berenguer, Ángela Gil-Martin, Inmaculada Jarrin, et al.
HIV Medicine|January 17, 2022
Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019Chiara Fanciulli, Juan Berenguer, Carmen Busca, et al.
Open Forum Infectious Diseases|January 23, 2018
Human Immunodeficiency Virus/Hepatits C Virus Coinfection in Spain: Elimination Is Feasible, but the Burden of Residual Cirrhosis Will Be SignificantJuan Berenguer, Inmaculada Jarrín, Leire Pérez-Latorre, et al.
Pageof 2